ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology

MOUNTAIN VIEW, Calif., December 19, 2023--ImpriMed Raises $23 Million Series A Round to Expand its Revolutionary AI-Powered Cancer Treatment Technology

Related Keywords

United States ,Han River ,South Korea General ,South Korea ,Samyang ,Ch Ungch Ong Bukto ,Korea ,Jay Choi ,Mary Placido ,Innovation Fund ,Stanford University ,Samyang Chemical Group ,Korea Advanced Institute Of Science ,Skc Inc ,Drug Administration ,Sk Telecom ,Softbank Ventures Asia ,River Partners ,Ignite Innovation Fund ,Murex Partners ,Sungwon Lim ,Jamin Koo ,Korea Advanced Institute ,Korea Food ,Silicon Valley ,Cancer Treatment ,Precision Medicine ,Cancer Cells ,Artificial Intelligence ,Cancer Patients ,Drug Response ,Veterinary Medicine ,Veterinary Hospitals ,Canine Cancer ,Blood Cancer ,